AortaHub’s Post

🔬We share with you the results of the study conducted by Fondazione Policlinico Universitario Campus Bio-Medico and Diapath S.p.A! 📚 The study published in the Italian Journal of Prevention, Diagnostic and Therapeutic Medicine concerns the Galileo Series 2 microtome, in combination with the PRO SYSTEM.   👩🔬 The device allows to #store and #save the position of the #roughing of all histological samples and to recall the position, at the time of cutting, automatically. This innovation not only optimizes work, but also increases laboratory productivity and overall efficiency. 👉 Read the full article on the study: https://lnkd.in/evadASd 👉 Discover more about Galileo Series 2:  https://lnkd.in/evadASd Special thanks to: Roberto Virgili Carmelo Lupo Clara Pecorella Chiara Giangare Fabrizio De Angelis Valentina Bartolucci Arianna Costantini Martina D’Angelo Fondazione Policlinico Universitario Campus Bio-Medico SIMEDET-Società Italiana Medicina Diagnostica e Terapeutica

📢 #MITMEVA is a project implemented at Hospital Clínic de Barcelona over the last years to have an integral, transversal and multidisciplinary management of aortic valve stenosis (#AS) aimed at improving the quality and efficiency of the clinical care of patients with AS. As a #publicprocurement of #innovation #MITMEVA included several technological and process improvements along the care pathway, providing the highest #value to patients and #healthsystems: from the appropriate referral to the hospital and diagnosis, to the most precise risk stratification, the optimization of diagnosis and treatment (involving all the actors - professionals, patients and family members) and the continued social and psychological support for these patients, among others. One of the actions in #MITMEVA was to implement an educational program for the general population in order to improve the recognition of AS and its symptoms and allow for a timely contact to healthcare centers. I'm happy to share that last month our letter to the editor was accepted, titled "Impact of education on aortic stenosis awareness in the general population". You can access it here 👇 https://lnkd.in/dA2k8-R6 I want to thank all my co-authors in this project, especially Marta Sitges and Bàrbara Vidal for leading the project on the clinical side from the Cardiovascular Institute at Hospital Clínic de Barcelona, Laura Sampietro-Colom for being the mind behind its evaluation and Paloma Gonzalez as a great partner from #MedTech. Two abstracts were already presented a couple of weeks ago at this year's #HTAi2024 annual meeting on the #evaluation of #MITMEVA 's #costeffectiveness and an assessment of its #scalability to other Catalan hospitals. Keep an eye out for the manuscripts in the coming months! #valuebasedhealthcare #vbhc

Earlier this week, our colleagues Vincenzo Carbone, PhD and Dorina Stanculescu attended the 8th plenary meeting of the BRAINTEASER Project held in Lisbon, Portugal. It was a great opportunity to present and discuss about the latest updates on the project. On IST side, we shared news about the tasks we're leading related to 𝗘𝘅𝗽𝗹𝗼𝗶𝘁𝗮𝘁𝗶𝗼𝗻 𝗣𝗹𝗮𝗻, 𝗥𝗶𝘀𝗸 𝗠𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁 and the 𝗔𝗜 𝗦𝗶𝗺𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗦𝗼𝗳𝘁𝘄𝗮𝗿𝗲 𝗖𝗹𝗼𝘂𝗱 𝗣𝗹𝗮𝘁𝗳𝗼𝗿𝗺. #BRAINTEASER is a #datascience project aiming to leverage the value of #bigdata, including information related to #health, #lifestyle habits, and #environment, to support #patients with amyotrophic lateral sclerosis #ALS and multiple sclerosis #MS, as well as their #clinicians. ℹhttps://lnkd.in/dhY2Fb4R Universidad Politécnica de Madrid Università degli Studi di Padova FCiências .com Università degli Studi di Torino Instituto de Medicina Molecular Servicio madrileño de salud (SERMAS) FONDAZIONE ISTITUTO NEUROLOGICO NAZIONALE CASIMIRO MONDINO Belit ECHAlliance - The Global Health Connector European Brain Council

🚀 Tackling Global Health Challenges Through Biomedical Engineering 🧬 As chronic #diseases and an ageing population strain our societies, #innovative #solutions are urgently needed. At Helmholtz-Gemeinschaft Biomedical Engineering, we're transforming groundbreaking #biomedical discoveries into practical #healthcare innovations. As Germany's largest research organization, the Helmholtz-Gemeinschaft, is uniquely positioned to lead in this space. Our bioengineers blend medical insights with cutting-edge #technology to pioneer better prevention, earlier detection, and more precise treatments. Together, we're shaping the #future of #healthcare, turning knowledge into life-saving solutions. 🌍💡 Find more info here: https://lnkd.in/eh9qJMAN In cooperation with: DKFZ Deutsches Krebsforschungszentrum Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) Forschungszentrum Jülich Helmholtz Munich Helmholtz-Zentrum Dresden-Rossendorf (HZDR) Helmholtz-Zentrum Hereon Helmholtz-Zentrum für Infektionsforschung Karlsruher Institut für Technologie (KIT) Max Delbrück Center #BiomedicalEngineering #Healthcare #HealthTech #Bioengineering

🧬 This week's Austin Bio & Health Roundup features key insights from other regions, exciting funding news, major research advancements, and significant developments across the Texas Bio Triangle. 🧬 💡Insights from Other Regions & My 2 Cents Patrick Sisson in Bisnow reported on the Research and Development District in downtown San Diego, a 1.7M sqft multi-use life sciences project. Costing $915M, it has 0 signed tenants just months before opening. Don’t forget that the San Diego region is one of the world’s top Bio & Health clusters. The critical issue: "To this day, much of the life sciences real estate in San Diego tends to be more office park or campus-style sites that aren’t in walkable urban neighborhoods." So, what does this have to do with Austin? You need alignment between location, infrastructure, & sector. I am not convinced that 80%+ of Bio & Health companies work downtown. Keep this in mind when people pitch a downtown Austin Life Science Innovation district. 💰 Funding Workweek, a publishing platform for business professionals, closed a $12.5M Series A.  This is in the Roundup because their vertical, run by Blake Madden, focuses on healthcare. It’s also another case of Austin funding Austin as the round was led by Next Coast Ventures. Congrats Adam Ryan! Koda Health, a digital care coordination company for advance planning, raised its oversubscribed Seed+ round led by Austin’s own Ecliptic Capital. Super pumped for you Tatiana Fofanova, Ph.D.! 🔬 Research & Medical Advancements Eliah Overbey, Professor of BioAstronautics (what a cool era we live in) at Austin’s newest university, the University of Austin, published a series of studies in Nature on what space flight does to humans. Professor Overbey led a multi-institutional research team that obtained 3,000 samples from the SpaceX 2021 Inspiration 4 flight, resulting in a “10-fold increase in publicly available human space cell health data." 🏆 Recognition Christian Keil & Ryan M.’s BuildList, a viral database of critical tech companies, features numerous Austin companies including Paradromics Inc. & Harmonic Bionics, Inc. in Bio & Health. Way to go Matt Angle and Mark Hunter! 🚀 Launches, Expansions, and Milestones Wheel launched Horizon, their new AI virtual care platform with predictive care pathways and configurable, patient-centered care programs. Amazing work Michelle Davey! Keyspan is bringing their affordable biomarker testing and personalized coaching to Austin Simply Fit to enhance their fitness programs. Kudos Nate Taylor! 🏙️ Community Join the BrainCheck-Alzheimer’s Association brain health panel on June 20th, featuring Briaincheck CEO Kim Rodriguez. Link to the event in the comments. I’ll be attending & hope to see you there! 🚩 Texas Bio Triangle Solugen, a synthetic biology unicorn, secured a $214 million loan from the Energy Department to build a Bioforge, marking a significant step for Houston’s industrial bio sector. What’s Next?

An aneurysm is a life-threatening inflation of an artery, often the aorta. What if we could use low-cost and efficient ultrasounds to monitor patients? Ultrasound imaging quality is usually not as good as CT scans. To improve the quality, PhD graduate Esther Maas developed a working 3D+t ultrasound imaging method. By combining ultrasound imaging in different directions to create a 3D image, and by looking at the moving images (adding the dimension of time), the imaging results can be just as effective and accurate. Her research was performed at Catharina Hospital Eindhoven and TU/e, and part of the Eindhoven MedTech Innovation Center (e/MTIC) . This would lower the costs of monitoring patients with an aneurysm and offer clinicians the right information to offer patient-specific care. Read more 👉 https://lnkd.in/e6_Tg4_T

The Chan Zuckerberg Initiative (CZI), led by Mark Zuckerberg and Priscilla Chan, has secured a key location in New York City’s Manhattanville Factory District in West Harlem to advance its ambitious bioengineering efforts. Situated within the historic Studebaker Building at 615 West 131st Street, this space is part of Columbia University’s ongoing expansion into the Manhattanville area. The Studebaker Building, originally constructed in the 1920s for the Studebaker automobile company, is now a key component of Columbia’s new research and academic facilities. The new space, covering 37,840 square feet, will house the Chan Zuckerberg Biohub New York. This cutting-edge research lab will facilitate collaboration among scientists from Columbia University, The Rockefeller University, and Yale University. The Biohub’s mission focuses on decoding the interactions among immune cells to detect and fight diseases such as cancer and neurodegenerative disorders. As President Andrea Califano explained, the lab aims to leverage advanced bioengineering techniques to create new tools that can detect disease at early stages. This New York Biohub is the fourth addition to the Chan Zuckerberg Biohub Network, following similar facilities in San Francisco, Chicago, and Redwood City, California. The New York location, backed by $300 million in funding—$250 million from CZI and $20 million from state and city support—aims to strengthen the city’s status as a leader in life sciences research and innovation. New York Governor Kathy Hochul and Mayor Eric Adams, who announced $10 million in state and city contributions each, highlighted the Biohub’s potential to drive scientific breakthroughs, economic growth, and job creation in the life sciences sector. By choosing Manhattanville, CZI is tapping into a vibrant hub of scientific research and innovation, further solidifying the neighborhood’s role in advancing biomedical breakthroughs. #ChanZuckerbergInitiative #Bioengineering #LifeSciences #Manhattanville #ColumbiaUniversity #ScientificCollaboration #NYCInnovation #BiomedicalResearch #CZBiohub #HealthcareInnovation

Danube Private University Austria (DPU) expands its research laboratories in the fields of “Medical Image Analysis & AI” and “Life Sciences & Technology”. Since January 2024, the Medical Image Analysis & Artificial Intelligence (MIAAI) and the International Laboratory for Life Sciences & Technology (LiST) have expanded their laboratories to Wiener Neustadt’s Technology and Research Centre (TFZ Wiener Neustadt) in Lower Austria. AI, Imaging and Analysis methods are being used in the department MIAAI led by Prof. Dr. Ramona Woitek and Prof. Dr. Julia Furtner-Srajer for diagnostic and prognostic purposes in medical care. Specialist fields of expertise within the MIAAI research team include breast and ovarian cancer and neurological cancer. Within the LiST Research Group led by Prof. Dr. Christoph Kleber, innovative smart sensor systems for personalized medicine and disease prevention are being developed contributing to significant breakthroughs in healthcare treatment. #highereducation #medicine #dentistry #healthcare #healthcareinnovation #diagnosis #research #medicalimaging #ai #radiomics #deeplearning #oncologyresearch #lifesciences #danubeprivateuniversity #austria #niederösterreich

New scientific publication! 📢 We are thrilled to announce that the results of a new clinical trial have been published in Frontiers 🎉 This multicentric study investigated the feasibility and usability of the ABLE Exoskeleton (clinical use device) for individuals with spinal cord injury to perform skills for home and community environments. The results and feedback gathered have been crucial for the development of our novel personal-use exoskeleton that we aim to launch in 2 years. Stay tuned! 🚀 The supervised use in the clinical environment has been a highly valuable approach for identifying the challenging tasks and the necessary technological developments needed for a personal-use exoskeleton 🏡 : ✅ A more independent sit-to-stand ✅ Faster speed of transitions between states ✅ A richer display on the remote control for the user ✅ Higher walking speed to improve access to community environments This study was conducted in two prestigious European #SCI centres: Institut Guttmann and University Hospital Heidelberg, and funded by EIT Health. We are deeply grateful for your ongoing support and collaboration! A huge thank you to all the authors for the great work and efforts put into this project, without you ABLE would not be what it is today. It has been a tremendous pleasure to collaborate with you the last few years and we hope to continue collaborating in the near future! 👨⚕️👩⚕️Mark Wright, Eloy Opisso, Helena Lopez Matas, Erika Porras Martínez, Alfons Carnicero Carmona, Cornelia Hensel, Franziska Nadorf, Steffen Franz, Norbert Weidner, Joan Vidal & Rüdiger Rupp Read the full article here! 👉 https://lnkd.in/dkKVG8rF Curious about all the scientific publications on the ABLE Exoskeleton? Learn about them here 👉 https://lnkd.in/db3PfmcP   #ClinicalResearch #ClinicalTrial #User-centered #MedicalTechnology #ABLEHumanMotion #ExoskeletonTechnology #SpinalCordInjury #Neuro #Rehabilitation #Innovation #MobilityForAll #FrontiersInScience

To close out Day 1 of Octane’s Medical Innovation Forum, our “Innovations and Impact: The Neurovascular Frontier in Orange County” panel highlighted the convergence of neurovascular and neuroscience advancements right here in Southern California. With expert insights from Mark Dickinson, World Wide President Neurovascular at Johnson & Johnson MedTech; Jag Dosanjh, President Neurosciences & Eye, SVP at AbbVie; and Azadeh Nasibi, Vice President of Business Development at Medtronic’s Neurovascular Operating Unit, the discussion explored how collaborative efforts in Orange County are accelerating breakthroughs to address complex neurological conditions. Moderated by Khurram Mir, Director of Innovation at UCI Health, the panel emphasized the significance of Orange County as a thriving hub for neruo innovation. Dickinson discussed the critical role of nurturing local talent and creating a collaborative ecosystem, while Dosanjh highlighted how forums like these foster connections between scientists, investors, and startups to propel innovation forward. Nasibi emphasized the substantial opportunities for stakeholders to advance treatments, particularly with approved therapies that are still underutilized. This panel offered a preview of what’s to come at the Neuro Tech Forum in April 2024, setting the stage for Orange County as a global leader in neurovascular and neuroscience innovation. We look forward to welcoming trailblazers from across the industry to continue building on these impactful discussions. #OMIF2024 #NTF2025 #FoundingPartners